New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing
The findings demonstrated that in the majority of cases (78%), the test’s CSO-directed initial diagnostic evaluation led to a diagnostic resolution.
- The findings demonstrated that in the majority of cases (78%), the test’s CSO-directed initial diagnostic evaluation led to a diagnostic resolution.
- The findings were presented during a poster discussion session at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
- Of those, the test’s CSO-directed predictions led to diagnostic resolution in 78% of cases (25/32).
- Although whole-body imaging was useful for hematologic and indeterminate CSOs, it did not contribute to diagnostic resolution in 51% of the participants (20/39).